BEBO HEALTH: ACHIEVES A VERY SOLID FIRST HALF AND SHARPENS ITS AMBITIONS


Press release / 30.07.22

BEBO HEALTH SA HAS A VERY SOLID FIRST HALF

AND SHARPEN ITS AMBITIONS

Geneva, Switzerland, July 30, 2022. BEBO realizes 2,552 MCHF in revenue in the first half of 2022. This is 27% more than in 2021 and in line with our budget forecasts.

The very important point is that this objective is achieved without the support of investors or third-party funding. We achieve our objectives with our own means and we guarantee an EBITDA at least equivalent to that of 2021 (18.5%). The shareholders present at the IPO are directly involved in this success.

BEBÔ now wants to grow faster, the three departments of its activity are operational:

  • E-COMMERCE:a completely in-house digital operations team.
  • SALES TO PROFESSIONALS: the latter have resumed since the end of the restrictions linked to the
    COVID.
  • BEBO HUB: Four openings in the first half of 2022 and a popular concept. At least six additional openings are planned for the second half of 2022.

Request information about each of our departments and LIVE BEBO!

JACQUES BORGOGNON, PRESIDENT OF BEBO HEALTH SA: “We are aware of our mission, to lead the company towards a significant volume of business while preserving profitability, which remains our priority. To evolve, we need investors who will enable us to achieve our objectives.

I want to remind you in this message that the main shareholder CES Management SA invested more than 4.0 MCHF to guarantee a good IPO. We converted this shareholder loan into Share Capital for a valuation of €18.50/share, proof of the confidence placed in BEBÔ. CES Management SA remains the leading investor.

Our specialists have prepared the implementation of convertible bonds that will simply allow each investor to participate in our development. The REYL bank in Geneva will be responsible for this operation.

We are also aware that shareholders must be able to easily buy or sell their shares. The results of the first half encourage us to prepare our evolution on EURONEXT GROWTH. For information, the volumes of shares traded on the Paris Stock Exchange are as follows:

  • ACCESS: €23 million in annual exchanges for 136 companies
  • GROWTH: €4,275 million in annual exchanges for 252 companies
  • i.e. 100 times more for GROWTH!

Press release / 30.07.22

BEBO HEALTH SA: “ON THE WAY FOR EURONEXT GROWTH” : The necessary steps to evolve on GROWTH are:

  • Raising €2.5 million.
  • Prepare due diligence based on the results of the first half of 2022.
  • Stay within our 2022 objectives.
  • Communicate more to potential shareholders and investors

For all these points, the BEBO HEALTH SA team is ready.

www.be-bo.eu

DISCLAIMER

  • This document does not constitute an offer to sell or a solicitation of an offer to buy BEBO Health SA securities. If you wish to obtain more complete information concerning BEBO Health SA, we invite you to refer to the public documents available on our website. (https://bourse.be-bo.eu/). This document can contain certain forward-looking statements. Although the Company believes that these statements are based on reasonable assumptions at the date of publication of this press release, they are by their nature subjectto risks and uncertainties that could lead to a difference between the actual figures and those indicated or implied in these declarations. »

CONTACT

BEBO Health SA

Jean-Charles Juriens

General secretary

E-mail : [email protected]

Telephone : +41 79 353 38 44



Source link -88